Search

Your search keyword '"Shannon J. McCall"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Shannon J. McCall" Remove constraint Author: "Shannon J. McCall" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
99 results on '"Shannon J. McCall"'

Search Results

1. Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States

2. Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers

3. Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies

4. Automated next-generation profiling of genomic alterations in human cancers

5. X-ray fan beam coded aperture transmission and diffraction imaging for fast material analysis

6. Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

7. Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence

8. Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and DifferentiationSummary

9. A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution

10. Supplementary Table 1 from A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer

12. Ensuring remote diagnostics for pathologists: an open letter to the US Congress

13. Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy

14. Table S2 from Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

15. Data from Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

16. Figure S2 from Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

18. Plasma cells are essentially absent in the luminal gastrointestinal tract of patients with 'complete' 22q11.2 deletion syndrome (DiGeorge syndrome)

19. Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University Experience

20. Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry

21. Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers

22. Abstract 930: Treatment patterns and overall survival among men with metastatic castration-resistant prostate cancer harboring DDR mutations

23. Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers

24. PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma

25. Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility

26. The Project Baseline Health Study: a step towards a broader mission to map human health

27. State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials—A Multidisciplinary Approach

29. Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy

30. A Hybrid Human-Machine Learning Approach for Screening Prostate Biopsies Can Improve Clinical Efficiency Without Compromising Diagnostic Accuracy

31. X-ray fan beam coded aperture transmission and diffraction imaging for fast material analysis

32. Truncated Caveolin-3 Mutation In Familial Barrett’s Esophagus

33. Automated next-generation profiling of genomic alterations in human cancers

34. Abstract 1061: Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma

35. Biobanking in the COVID-19 era and beyond: Part 1. How early experiences can translate into actionable wisdom

36. Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers

37. Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies

38. A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer

39. A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma

40. RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestry

41. Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma

42. Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer

43. Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients

45. The College of American Pathologists Biorepository Accreditation Program: Results from the First 5 Years

46. Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas

47. Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

48. Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence

49. Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

50. Glycogenic Hepatopathy Causing Elevated Lactic Acid and Liver Enzymes

Catalog

Books, media, physical & digital resources